News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Guillermo Villacampa: The safety and efficacy of ADCs with immunotherapy
Guillermo Villacampa/ vhio.net
Oct 20, 2024, 10:56

Guillermo Villacampa: The safety and efficacy of ADCs with immunotherapy

Guillermo Villacampa, 

“Antibody-drug conjugate (ADCs) in combination with immunotherapy is emerging as a promising strategy. However, concerns arise regarding the safety.

In this work, we present a combined analysis evaluating the safety and efficacy of this combination.”

Guillermo Villacampa

Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis

Authors: Guillermo Villacampa, Pablo Cresta Morgado, Lorenzo Carità, Victor Navarro, Tomas Pascual and Rodrigo Dienstmann.

Guillermo Villacampa

 

ADC Antibody-drug conjugate (ADCs) cancer cancer awareness cancer care fight against cancer Global fight against cancer Guillermo Villacampa immunotherapy Lorenzo Carità OncoDaily Oncology Pablo Cresta Morgado Rodrigo Dienstmann Tomás Pascual VHIO Victor Navarro
Special Coverage
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology